Governance Classic Home
Bliss GVS Pharma LtdPharmaceuticalsINE416D01022Consolidated₹680.40-9.70 (-1.41%)Jun-26
Valuation
Market Cap₹7.23K Cr
TTM PE52.94x
Forward PE49.65x
PEG9.97
Book Value₹112.48
P/B6.06x
TTM EPS₹12.88
Fwd EPS₹13.73
TTM Revenue₹1.01K Cr
TTM PAT₹141.74 Cr
TTM EBITDA₹187.40 Cr
TTM EBIT₹152.18 Cr
Last Qtr PAT₹51.37 Cr
Last Qtr EBITDA₹76.41 Cr
Last Qtr EBIT₹66.47 Cr
Profitability
ROE11.88%
ROCE17.21%
TTM NPM14.10%
TTM EBITDA %18.64%
Curr OPM17.40%
Last OPM13.80%
Curr NPM—
Last NPM—
Curr EPS₹4.73
Last EPS₹3.37
Balance sheet
Equity₹10.58 Cr
Reserve₹1.18K Cr
Total Debt₹21.75 Cr
D/E0.02x
Interest %1.13%
Curr Interest₹0.58 Cr
Price / range
Close₹681.85
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-1.27%
1W-5.82%
1M+24.74%
3M+41.25%
6M+215.29%
1Y+344.35%
2Y+433.11%
3Y+638.17%
5Y+503.14%
Diwali+320.90%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue221.59+35.6%211.54164.68190.23163.36729.81
Other Income8.769.3010.2325.8510.5943.72
Total Income230.35+32.4%220.84174.91216.07173.96773.53
Interest0.391.811.482.725.1111.11
Expenditure-179.14-24.9%-177.04-147.11-182.61-143.39-637.91
PBDT000000
EBITDA51.87+58.3%44.1526.8518.0332.76134.03
Depreciation-9.03-7.84-7.80-7.69-7.68-31.02
EBIT42.84+70.8%36.3119.0510.3425.08103.01
PBT51.21+67.6%44.1525.2933.4630.56133.46
Tax-12.59-11.73-6.68-8.66-9.51-36.59
Equity10.6110.580010.5510.58
OPM22.2319.9915.3617.5917.5717.25
Net Profit38.62+83.5%32.4218.6124.7921.0596.87
NPM16.7714.6811.3013.0312.1012.52
EPS3.65+82.5%3.061.762.3529.17

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue729.81+9.4%667.20+10.2%605.46+1.2%598.34-6.0%636.36+36.7%465.51
Other Income43.7236.2233.5050.7732.6317.68
Total Income773.53+10.0%703.42+10.1%638.96-1.6%649.11-3.0%668.99+38.4%483.20
Expenditure-637.91-4.7%-609.25-15.5%-527.62+1.1%-533.41+2.2%-545.33-39.1%-392.01
Interest-11.11-6.58-5.81-10.06-4.32-4.19
PBDT000000
EBITDA134.03+46.4%91.58-14.5%107.17+18.9%90.16-17.4%109.20+19.4%91.45
Depreciation-31.02-27.05-23.52-15.17-13.85-13.76
EBIT103.01+59.6%64.53-22.9%83.65+11.5%74.99-21.4%95.35+22.7%77.69
PBT133.46+41.7%94.17+34.0%70.26-39.3%115.69-8.5%126.40+38.6%91.19
Tax-36.59-25.20-19.61-30.21-33.74-23.69
Equity10.5810.540000
OPM (%)17.2513.3911.0018.0019.0019.00
Net Profit96.87+40.5%68.97+36.2%50.65-40.7%85.48-7.7%92.66+37.3%67.50
NPM (%)12.529.808.0013.0014.0014.00
EPS (Rs)9.17+39.8%6.56+35.3%4.85-41.1%8.23-8.2%8.97+37.2%6.54
CEPS96.504.778.108.816.40

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue285.58+37.6%256.99218.25244.40207.47927.11
Other Income9.6011.1618.4620.1835.4573.53
Total Income295.18+21.5%268.15236.71264.58242.921,000.64
Interest0.582.011.493.045.4712.01
Expenditure-219.69-22.2%-223.23-193.30-223.94-179.81-808.57
PBDT000000
EBITDA76.41+84.9%44.4434.7931.7641.33164.03
Depreciation-9.94-8.67-8.35-8.26-8.20-33.48
EBIT66.47+100.6%35.7726.4423.5033.13130.55
PBT75.48+19.6%44.9540.9040.6363.11189.59
Tax-24.11-7.95-16.12-12.04-18.75-54.86
Equity10.6110.580010.5510.58
OPM25.5716.7617.2815.3625.9818.95
Net Profit51.37+15.8%3724.7828.5944.36134.73
NPM17.4013.8010.4710.8118.2613.46
EPS4.73+15.9%3.372.202.584.0812.23

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue927.11+14.5%809.73+5.1%770.25+2.5%751.59+0.6%747.45+29.5%577.21
Other Income73.5336.4928.7417.7931.4920.22
Total Income1,000.64+18.2%846.22+5.9%798.98+3.8%769.37-1.2%778.95+30.4%597.43
Expenditure-808.57-12.2%-720.58-10.4%-652.91+1.6%-663.30-1.9%-651.19-32.0%-493.30
Interest-12.01-8.12-6.91-10.36-4.74-5.51
PBDT000000
EBITDA164.03+29.5%126.69-15.9%150.63+28.4%117.32-0.9%118.33+11.0%106.65
Depreciation-33.48-29.42-26.38-18.67-17.33-17.23
EBIT130.55+34.2%97.27-21.7%124.25+26.0%98.65-2.3%101+13.0%89.42
PBT189.59+50.9%125.64+7.5%116.87+10.2%106.07+95.8%54.17-48.0%104.13
Tax-54.86-35.38-35.29-29.34-31.04-30.16
Equity10.5810.540000
OPM (%)18.9514.8514.6313.796.9517.43
Net Profit134.73+49.3%90.26+10.6%81.58+6.3%76.74+231.8%23.13-68.7%73.97
NPM (%)13.4610.6710.219.972.9712.38
EPS (Rs)12.23+52.5%8.02+10.9%7.23+5.9%6.83+367.8%1.46-78.0%6.64
CEPS127.957.116.721.436.49

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

24
YearTypeAmountEx-Date
2026Final Dividend108 Jul 2026
2026Interim Dividend0.518 Feb 2026
2025Final Dividend0.524 Jul 2025
2024Final Dividend0.518 Jul 2024
2023Final Dividend0.512 Jul 2023
2022Final Dividend0.520 Jun 2022
2021Final Dividend0.513 Sep 2021
2020Final Dividend0.517 Sep 2020
2019Final Dividend112 Sep 2019
2018Final Dividend114 Aug 2018
2017Final Dividend0.618 Sep 2017
2016Final Dividend0.506 Sep 2016
2015Final Dividend0.508 Sep 2015
2015Interim Dividend0.224 Feb 2015
2014Final Dividend0.513 Aug 2014
2013Final Dividend0.401 Aug 2013
2013Interim Dividend0.325 Feb 2013
2012Final Dividend0.402 Aug 2012
2012Interim Dividend0.3524 Nov 2011
2011Final Dividend0.314 Jul 2011
2011Interim Dividend0.325 Nov 2010
2010Final Dividend0.522 Jul 2010
2009Final Dividend0.1513 Aug 2009
2009Interim Dividend0.114 May 2008

Bonus

1
YearRatioEx-Date
20083:526 Sep 2008

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers